<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="5811">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091155</url>
  </required_header>
  <id_info>
    <org_study_id>Protocol COMPRES 23/11/2009</org_study_id>
    <nct_id>NCT01091155</nct_id>
    <nct_alias>NCT00859924</nct_alias>
  </id_info>
  <brief_title>COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study</brief_title>
  <acronym>COMPRES</acronym>
  <official_title>COMPRES - COMpression Anastomosis Ring (CAR™ 27/ColonRing™) Post maRketing Evaluation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>novoGI</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Atlanta Colon &amp; Rectal Surgery, Atlanta, GA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>FPMG Center for Colon &amp; Rectal Surgery</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lester E. Cox Medical Centers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UCI Medical Center Irvine CA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NorthShore University HealthSystem Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>St.Louis University hospital MO</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Southern California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Barmherzig Brueder</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ziekenhuis Oost-Limburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital, Gasthuisberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Klinikum Neuperlach</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>novoGI</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
    <authority>Belgium: Institutional Review Board</authority>
    <authority>Germany: Ethics Commission</authority>
    <authority>Netherlands: Independent Ethics Committee</authority>
    <authority>Israel: Ethics Commission</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The performance of the ColonRing™ will be comparable to or better than the reported
      performance of staplers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The proposed study is a post marketing study intended to gather and record additional data
      to further evaluate the performance of the ColonRing™ device in regards to the creation of a
      colorectal anastomosis.

      The study objective is to evaluate the performance of the ColonRing™ in the creation of a
      circular anastomosis in colorectal procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">July 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>To Evaluate Rate of Anastomotic Leaks Related to the Use of the ColonRing™ Device, at 1 Month</measure>
    <time_frame>Approx. 1 year</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device Related Leak Rate up to 30 Days Post op</measure>
    <time_frame>30 days post op</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Other Device Related Complications and Other Parameters During Hospitalization and Post Procedure.</measure>
    <time_frame>30 days post op</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The post operative parameters that will be measured during hospitalization period:
Hospitalization time (two dates will be recorded: ready for discharge and discharge). The later noting where the subject was discharged to - e.g. nursing home or home
First day to first postoperative flatus
First day to first postoperative bowel movements
First day of first postoperative toleration of liquids and solids (time to &quot;keeping them down&quot;)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">288</enrollment>
  <condition>Colorectal Surgery</condition>
  <arm_group>
    <arm_group_label>ColonRing TM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ColonRing (Colorectal anastomosis)</intervention_name>
    <description>Creation of a colorectal compression anastomosis</description>
    <arm_group_label>ColonRing TM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is ≥ 18 years old.

          2. BMI &lt; 34.

          3. Subject is planned to undergo a non-emergency (i.e., elective) operation with the
             creation of an anastomosis using the ColonRing™.

          4. Subject signs and dates a written informed consent form (ICF) and indicates an
             understanding of the study procedures.

        Exclusion Criteria:

          1. Subject has a known allergy to nickel.

          2. Subject is planned to undergo an emergency procedure or has a diagnosis of bowel
             strangulation, peritonitis, bowel perforation, local or systemic infection, ischemic
             bowel,carcinomatosis.

          3. Subject has participated in another clinical study which may affect this study's
             outcomes within the last 30 days.

          4. Subject's ASA (American Society of Anesthesiology) score 4 or 5.

          5. Subject has a concurrent or previous invasive pelvic malignancy.

          6. Subject has a systemic or incapacitating disease.

          7. Subject has extensive local disease in the pelvis.

          8. Subject requires more than one anastomosis during the surgery.

          9. Women who are known to be pregnant.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eran Choman, Msc</last_name>
    <role>Study Director</role>
    <affiliation>novoGI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCI Medical Center</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Southern California Health Sciences Campus</name>
      <address>
        <city>Los-Angeles</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FPMG Center for Colon &amp; Rectal Surgery</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Regional Medical Center</name>
      <address>
        <city>Riverdale</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NorthShore University Health System</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lester E. Cox Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis University Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KH Barmherzig Brueder</name>
      <address>
        <city>Vienna</city>
        <zip>A-1020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ziekenhuis Oost Limburg</name>
      <address>
        <city>Genk</city>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Neuperlach</name>
      <address>
        <city>Munich</city>
        <zip>81737</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bnai Zion Medical Center</name>
      <address>
        <city>Haifa</city>
        <zip>31048</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Israel</country>
    <country>Netherlands</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.nitisurgical.com/</url>
    <description>Click here for more information about study device (sponsor's web site)</description>
  </link>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 20, 2013</lastchanged_date>
  <firstreceived_date>March 19, 2010</firstreceived_date>
  <firstreceived_results_date>June 4, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colon Anastomosis</keyword>
  <keyword>Rectum Anastomosis</keyword>
  <keyword>Intestine</keyword>
  <keyword>Colorectal Surgery</keyword>
  <keyword>Colorectal Anastomosis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ColonRing TM</title>
          <description>ColonRing (Colorectal anastomosis) : Creation of a colorectal compression anastomosis</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="288"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="279"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ColonRing TM</title>
          <description>ColonRing (Colorectal anastomosis) : Creation of a colorectal compression anastomosis</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="288"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="177"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="111"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="60" spread="13.4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="146"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="142"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="127"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Belgium</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="83"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Austria</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="46"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Israel</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="13"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Germany</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="9"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Netherlands</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>To Evaluate Rate of Anastomotic Leaks Related to the Use of the ColonRing™ Device, at 1 Month</title>
        <description>Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.</description>
        <time_frame>Approx. 1 year</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Other Device Related Complications and Other Parameters During Hospitalization and Post Procedure.</title>
        <description>The post operative parameters that will be measured during hospitalization period:
Hospitalization time (two dates will be recorded: ready for discharge and discharge). The later noting where the subject was discharged to - e.g. nursing home or home
First day to first postoperative flatus
First day to first postoperative bowel movements
First day of first postoperative toleration of liquids and solids (time to &quot;keeping them down&quot;)</description>
        <time_frame>30 days post op</time_frame>
        <safety_issue>Yes</safety_issue>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Device Related Leak Rate up to 30 Days Post op</title>
        <description>Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.</description>
        <time_frame>30 days post op</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>ColonRing TM</title>
            <description>ColonRing (Colorectal anastomosis) : Creation of a colorectal compression anastomosis</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="279"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Device Related Leak Rate up to 30 Days Post op</title>
            <description>Anastomotic leakage will be defined as clinical symptoms such as fever or sepsis in combination with pelvic abscess, rectovaginal fistula or peritonitis within 30 days postoperatively leading to a clinical and / or radiological interventional procedure of the subject, or operation that confirms the leakage which has been determined to be related to the device.</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="4"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>ColonRing TM</title>
          <description>ColonRing (Colorectal anastomosis) : Creation of a colorectal compression anastomosis</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="279"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Leak</sub_title>
                <counts group_id="E1" events="26" subjects_affected="16" subjects_at_risk="279"/>
              </event>
              <event>
                <sub_title>Abscess</sub_title>
                <counts group_id="E1" events="26" subjects_affected="8" subjects_at_risk="279"/>
              </event>
              <event>
                <sub_title>Fistula</sub_title>
                <counts group_id="E1" events="26" subjects_affected="2" subjects_at_risk="279"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="279"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>14.1 Review. Institution may publish the results of the Study, based on information collected or generated by Institution and Principal Investigator within the framework thereof, subject to the provisions of this section. In any event, however, no publication, presentation in any forum or any other form of disclosure with respect to the Study or the results thereof will be made prior to the publication of the Joint Publication without Sponsor’s prior written consent.</restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>The study had acceptable rate of AE, and technical problems.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Eran Choman, VP Clinical Affairs &amp; Statistics</name_or_title>
      <organization>novoGI</organization>
      <phone>+972 9 8603000</phone>
      <email>eran.choman@novogi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
